ESCC

Clinical trials for ESCC explained in plain language.

Never miss a new study

Get alerted when new ESCC trials appear

Sign up with your email to follow new studies for ESCC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New drug ALX2004 targets tough cancers in first human trial

Disease control Recruiting now

This early-phase study tests a new drug called ALX2004 in people with advanced or metastatic solid tumors (lung, head and neck, colorectal, or esophageal cancer) that have not responded to standard treatments. ALX2004 is an antibody-drug conjugate designed to deliver a cancer-kil…

Matched conditions: ESCC

Phase: PHASE1 • Sponsor: ALX Oncology Inc. • Aim: Disease control

Last updated Apr 29, 2026 04:27 UTC

ESCC

Get alerted when new ESCC trials appear

New drug ALX2004 targets tough cancers in first human trial